Tc-99m sestamibi scintimammography for the diagnosis of breast cancer: Meta-analysis and meta-regression

Nuclear Medicine Communications

Volumn 32, Issue 11, 2011, Pages 980-988

  Xu, Hong Bin ^a   Li, Ling ^a   Xu, Qing ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

breast cancer; diagnostic accuracy; sensitivity and specificity Tc 99m MIBI

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

BREAST CANCER; CANCER DIAGNOSIS; DATA BASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; META ANALYSIS; PERFORMANCE; PUBLICATION; REVIEW; SCINTIMAMMOGRAPHY; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMATIC REVIEW;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; MIDDLE AGED; ODDS RATIO; RADIOPHARMACEUTICALS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 80053509248     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32834b43a9     Document Type: Review

References (50)

1. Liberman M, Sampalis F, Mulder DS. Breast cancer diagnosis by scintimammography: a meta-analysis and review of the literature. Breast Cancer Res Treat 2003; 80:115-126. (Pubitemid 36851291)
2. Hussain R, Buscombe JR. A meta-analysis of scintimammography: an evidence-based approach to its clinical utility. Nucl Med Commun 2006; 27:589-594. (Pubitemid 44305315)
3. Deville WL, Buntinx F, Bouter LM. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Method 2002; 2:9.
4. Egger M, Davey-Smith G, Schneider M. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629-634. (Pubitemid 27387172)
5. Taillefer R, Robidoux A, Lampert R, Urpin S, Laperriere J. Technetium-99msestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995; 36:1758-1765.
6. Lu G, Shin WJ, Huang HY, Long MQ, Sun Q, Liu YH, et al. 99Tcm-MIBI mammoscintigraphy of breast masses early and delayed imaging. Nucl Med Commun 1995; 16:150-156.
7. Maffioli L, Agresti R, Chiti A, Crippa F, Gasparini M, Greco M, et al. Prone scintimammography in patients with non-palpable breast lesions. Anticancer Res 1996; 16:1269-1274.
8. Villanueva-Meyer J, Leonard MH, Briscoe E, Cesani F, Ali SA, Rhoden S, et al. Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer. J Nucl Med 1996; 37:926-930. (Pubitemid 126447123)
9. Clifford EJ, Lugo-Zamudio C. Scintimammography in the diagnosis of breast cancer. Am J Surg 1996; 172:483-486. (Pubitemid 26415756)
10. Ambrus E, Rajtar M, Ormandi K, Sera T, Toszegi A, Lang J, et al. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraph in evaluation of breast mass lesions. Anticancer Res 1997; 17:1599-1606.
11. Carril JM, Gomez-Barouin R, Quirce R, Quirce R, Tabuenca O, Uriarte I, et al. A. Contribution of 99mTc-MIBI scintimammography to the diagnosis of nonpalpable breast lesions in relation to mammographic probability of malignancy. Anticancer Res 1997; 17:1677-1682.
12. Buscombe JR, Cwikla JB, Thakrar DS, Hilson AJW. Uptake of Tc-99m MIBI related to tumour size and type. Anticancer Res 1997; 17: 1693-1694. (Pubitemid 27263147)
13. Becherer A, Helbich T, Staudenherz A, Jakesz R, Kubista E, Lehner R, et al. The diagnostic value of planar and SPET scintimammography in different age groups. Nucl Med Commun 1997; 18:710-718. (Pubitemid 27374886)
14. Scoparino F, Schillaci O, UssofW, Nordling K, Capoferro R, De Vincentis G, et al. A three center study on the diagnostic accuracy of 99mTc-MIBI scintimammography. Anticancer Res 1997; 17:1631-1634. (Pubitemid 27263136)
15. Chen SL, Yin YQ, Chen JX, Sun XG, Xiu Y, Liu WG, et al. The usefulness of technetium-99m-MIBI scintimammography in diagnosis of breast cancer: using surgical histopathologic diagnosis as the gold standard. Anticancer Res 1997; 17:1695-1698. (Pubitemid 27263148)
16. Wilczek B, Aspelin P, Bone B, Pegerfalk A, Frisell J, Danielsson R. Complementary use of scintimammography with 99m-Tc-MIBI to triple diagnostic procedure in palpable and non-palpable breast lesions. Acta Radiol 2003; 44:288-293.
17. Tiling R, KeXler M, Untch M, Sommerd H, Linke R, Hahna K. Initial evaluation of breast cancer using Tc-99m sestamibi scintimammography. Eur J Radiol 2005; 53:206-212. (Pubitemid 40143582)
18. Kim SJ, Kim IJ, Bae YT, Kim YK, Kim DS. Comparison of quantitative and visual analysis of Tc-99m MIBI scintimammography for detection of primary breast cancer. Eur J Radiol 2005; 53:192-198.
19. Peng NJ, Chang HT, Tsay DG, Liu RS. Technetium-99m-sestamibi scintimammography to detect breast cancer in patients with paraffinomas or siliconomas after breast augmentation. Cancer Biother Radiopharm 2003; 18:573-580.
20. Krishnaiah G, Sher-Ahmed A, Ugwu-Dike M, Regan P, Singer J, Totoonchie A, et al. Technetium-99m sestamibi scintimammography complements mammography in the detection of breast cancer. Breast J 2003; 9: 288-294. (Pubitemid 36927408)
21. Mekhmandarov S, Sandbank J, Cohen M, Lelcuk S, Lubin E. Technetium-99m-MIBI scintimammography in palpable and non-palpable breast lesions. J Nucl Med 1998; 39:86-91. (Pubitemid 28063176)
22. Colella AC, Scopinaro F, Schillaci O, Danieli R, Vincentis GD, Ierardi M, et al. 99mTc-sestamibi breast scintigraphy. Tumori 1997; 83:520-522. (Pubitemid 27314554)
23. Kao CH, Wang SJ, Liu TJ. The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 1994; 21:432-436. (Pubitemid 24135916)
24. Helbich TH, Becherer A, Trattnig S, Leitha T, Kelkar P, Seifert M, et al. Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography. Radiology 1997; 202:421-429. (Pubitemid 27051737)
25. Burak Z, Argon M, Memis A, Erdem S, Balkan Z, Duman Y, et al. Evaluation of palpable breast masses with 99Tcm-MIBI: a comparative study with mammography and ultrasonography. Nucl Med Commun 1994; 15:604-612. (Pubitemid 24259774)
26. Sampalis FS, Denis R, Picard D, Fleiszer D, Martin G, Nassif E, et al. International prospective evaluation of scintimammography with technetium-99m sestamibi: interim results. Am J Surg 2001; 182:399-403. (Pubitemid 33079095)
27. Lumachi F, Ferretti G, Povolato M, Marzola MC, Zucchetta P, Geatti O, et al. Usefulness of 99m-Tc-sestamibi scintimammography in suspected breast cancer and in axillary lymph node metastases detection. Eur J Surg Oncol 2001; 27:256-259. (Pubitemid 32621749)
28. Lantsberg L, Kirshtein B, Lantsberg S, Quastel MR. Mammoscintigraphy with Tc-99m sestamibi in the evaluation of benign and malignant breast disease. Breast J 1999; 8:40-43. (Pubitemid 29213382)
29. Marini C, Cilotti A, Traino AC, Bellina CR, Grosso M, Armillotta N, et al. Tc 99m-Sestamibi scintimammography in the di.erentiation of benign and malignant breast microcalcifications. Breast J 2001; 10:306-312. (Pubitemid 32694507)
30. Bagni B, Franceschetto A, Casolo A, DeSantis M, Bagni I, Pansini F, DiLeo C. Scintimammography with 99mTc-MIBI and magnetic resonance imaging in the evaluation of breast cancer. Eur J Nucl Med Mol Imaging 2003; 30:1383-1388. (Pubitemid 37247956)
31. Sun SS, Hsieh JF, Tsai SC, Ho YJ, Lee JK, Koa CH, et al. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women. Anticancer Res 2000; 20:2133-2136.
32. Wang HC, Sun SS, Kao A, Lin CC, Lee CC. Comparison of technetium-99m methoxyisobutylisonitrile scintimammography and ultrasonography in the diagnosis of breast cancer in patients with mammographically dense breast. Cancer Invest 2002; 20:318-323. (Pubitemid 34496564)
33. Palmedo H, Schomburg A, Grunwald F, Mallmann P, Boldt I, Biersack HJ. Scintimammography with Tc-99m MIBI in patients with suspicion of primary breast cancer. Nucl Med Biol 1996; 23:681-684. (Pubitemid 26342471)
34. Obwegeser R, Berghammer P, Rodrigues M, Granegger S, Hohlagschwandtner M, Kucera H, et al. A head-to-head comparison between technetium-99m-tetrofosmin and technetium-99m-MIBI scintigraphy to evaluate suspicious breast lesions. Eur J Nucl Med 1999; 26:1553-1559. (Pubitemid 30010292)
35. Howarth D, Sillar R, Clark D, Lan L. Technetium-99m sestamibi scintimammography: the influence of histopathological characteristics, lesion size and the presence of carcinoma in situ in the detection of breast carcinoma. Eur J Nucl Med 1999; 26:1475-1481. (Pubitemid 29515610)
36. Imbriaco M, Vecchio SD, Riccardi A. Scintimammography with 99mTc-MIBI versus dynamic MRI for non-invasive characterization of breast masses. Eur J Nucl Med 2001; 28:56-63. (Pubitemid 32120807)
37. Uriarte I, Carril JM, Quirce R. Optimization of X-ray mammography and technetium-99m methoxyisobutylisonitrile scintimammography in the diagnosis of non-palpable breast lesions. Eur J Nucl Med 1998; 25:491-496. (Pubitemid 28254593)
38. Palmedo H, Biersack HJ, Lastoria S. Scintimammography with technetium-99m methoxyisobutylisonitrile: results of a prospective European multicentre trial. Eur J Nucl Med 1998; 25:375-385. (Pubitemid 28211601)
39. Kim IJ, Kim YK, Kim SJ. Detection and prediction of breast cancer using double phase Tc-99m MIBI scintimammography in comparison with MRI. Onkologie 2009; 32:556-560.
40. Arslan N, Ozturk E, Ilgan S. The comparison of dual phase Tc-99m MIBI and Tc-99m MDP scintimammography in the evaluation of breast masses: preliminary report. Ann Nucl Med 2000; 14:39-46. (Pubitemid 30190878)
41. Kim IJ, Kim SJ, Kim YK. Comparison of double phase Tc-99m MIBI and Tc-99m tetrofosmin scintimammography for characterization of breast lesions: visual and quantitative analysis. Neoplasma 2008; 55:526-531.
42. Cutrone JA, Khalkhali I, Yospur LS, Diggles L, Weinberg I, Pong EM, et al. Tc99m sestamibi scintimammography for the evaluation of breast masses in patients with radiographically dense breasts. Breast J 1999; 5:383-388.
43. Alonso JC, Soriano A, Zarca MA. Breast cancer detection with sestamibi-Tc-99m and TI-201 radionuclides in patients with non-conclusive mammography. Anticancer Res 1997; 17:1661-1666.
44. Danielson R, Bone B, Gad A, Sylvan M, Aspelin P. Sensitivity and specificity of planar scintimammography with 99mTc-sestamibi. Acta Radiol 1999; 40:394-399. (Pubitemid 129567244)
45. Lam WWM, Yang WT, Chan YL, Stewart IE, King W, Metreweli C. Role of MIBI breast scintigraphy in evaluation of palpable breast lesions. Br J Radiol 1996; 69:1152-1158. (Pubitemid 27011194)
46. Melloul M, Paz A, Ohana G, Laver O, Michalevich D, Koren R, et al. Doublephase 99mTc-sestamibi scintimammography and trans-scan in diagnosing breast cancer. J Nucl Med 1999; 40:376-380. (Pubitemid 29120108)
47. Prats E, Aisa F, Abos DM, Villavieja L, Garcia-Lopez F, Asenjo MJ, et al. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer. J Nucl Med 1999; 40:296-301. (Pubitemid 29077093)
48. Khalkhali I, Villanueva-Meyer J, Edell SL, Tavolaro R, Picardi V, Cannas P, Colella AC. Diagnostic accuracy of 99mTc-sestamibi breast imaging: multicenter trial results. J Nucl Med 2000; 41:1973-1979. (Pubitemid 32038685)
49. Schillaci O, Scoparino F, Danieli R. 99Tcm-sestamibi scintimammography in patients with suspicious breast lesions: comparison of SPET and planar images in the detection of primary tumours and axillary lymph node involvement. Nucl Med Commun 1997; 18:839-845. (Pubitemid 27444595)
50. Petitti DB. Approaches to heterogeneity in meta-analysis. Stat Med 2001; 20:3625-3633. (Pubitemid 33114432)